AFFECTIVE MODELS OF DEPRESSION AND ANXIETY IN PATIENTS WITH PARKINSON DISEASE AND MULTIPLE SCLEROSIS
DOI:
https://doi.org/10.5457/ams.v51i1-2.579Keywords:
Emotional disorders, Parkinson 's disease, Multiple sclerosisAbstract
Introduction: Anxiety and depression include emotional disorders that occur associated with Parkinson's disease and multiple sclerosis can be an important sign of morbidity.
The aim of this study was to investigate the degree of emotional disorders in patients with Parkinson's disease (PD) and multiple sclerosis (MS).
Methods: The prospective study included 50 patients with PB and relapse of remitting MS, with a disease duration of 1-5 years, without cognitive impairment. According to the duration of the disease, the participants were divided into two groups. Clinical assessment of the degree of disability in MS subjects was performed by the Kurtzke Expanded Disability Status Scale (EDSS), and in PB subjects by the Hoehn and Year scales. Depression was measured by the Beck Depression Scale, anxiety by the Hamilton Scale for Anxiety Assessment.
Results: Moderate anxiety was shown by 36% and moderate and severe anxiety by 64% of PD participants. Anxiety does not depend on the duration of the disease, and is more pronounced in stage III and IV of the disease (P = 0.04). Depression is present in 82% of participants with PB. It occurs regardless of the duration of the disease. Advanced participants had a more severe form of depression (P = 0.01). Participants with MS showed moderate anxiety in 32% and moderate and severe anxiety in 68% of cases. The frequency of anxiety is independent of the duration of the disease (P = 0.87) and the degree of clinical disability (EDSS) (P = 1.0). Depression was found in 86% of MS participants. The frequency of depression is independent of the duration of the disease and the degree of clinical disability.
Conclusion: Emotional difficulties resulting from coping with severe chronic illness, with the interaction of genetic-biological and psychosocial factors result in the development of affective disorders such as depression and anxiety in patients with PB and MS.
Downloads
Published
Issue
Section
License
Copyright transfer
The listed authors warrant that they are the authors and sole owners of the submitted manuscript. The authors also warrant that the work is original; that it has not been previously published in print or electronic format and is not under consideration by another publisher or electronic medium; that it has not been previously transferred, assigned, or otherwise encumbered; and that the authors have full power to grant such rights. With respect to the results of this work, the manuscript of this or substantially similar content will not be submitted to any other journal until the review process in the Acta Medica Salinianana has been officially completed (acceptance or rejection of the manuscript). The paper will not be withdrawn from the review process by the Acta Medica Saliniana Editorial Board until the review process is completed. The authors will comply with the requests of the Acta Medica Saliniana Editors and reviewers to improve the paper for publication. The eventual disagreements will be submitted in a written form; the authors are aware that the disagreement(s) with the Acta Medica Saliniana requests may result in the rejection of the manuscript. The authors hereby grant to the Acta Medica Saliniana the right to edit, revise, abridge, and condense the manuscript. If the manuscript is accepted for publication in the Acta Medica Saliniana, the authors hereby transfer the copyright of the paper to the Acta Medica Saliniana. The authors permit the Acta Medica Saliniana to allow third parties to copy any part of the journal without asking for permission, provided that the reference to the source is given. For papers with more than one author: All other co-authors agree to allow the corresponding author to make decisions regarding prepublication release of the information in the paper to the media, federal agencies, or both.
